EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

NLRX1 ligand, docosahexaenoic acid, ameliorates LPS-induced inflammatory hyperalgesia by decreasing TRAF6/IKK/IκB-α/NF-κB signaling pathway activity

Dilsah Ezgi Yilmaz, Sefika Pinar Senol, Meryem Temiz-Resitoglu, Seyhan Sahan-Firat, Bahar Tunctan

Cellular and Molecular Biology · 2023

DOI: 10.14715/cmb/2023.69.9.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular and Molecular Biology, 2023. Verfasst von Dilsah Ezgi Yilmaz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey. dilsahezgikucuk@hotmail.com. Hauptthemen laut MEDLINE: NF-kappa B, I-kappa B Kinase. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The nucleotide-binding oligomerization domain-like receptor X1 (NLRX1) has been associated with various anti-inflammatory mechanisms. We investigated whether the NLRX1 ligand docosahexaenoic acid (DHA) ameliorates lipopolysaccharide (LPS)-induced inflammatory hyperalgesia by interacting with tumor necrosis factor receptor-associated factor 6 (TRAF6)/inhibitor of kB (IkB) kinase (IKK)/IkB-a/nuclear factor-κB (NF-κB) signaling pathway in the central nervous system. Reaction time to thermal stimuli within 30 seconds was measured in male mice injected with saline, lipopolysaccharide (LPS), and/or DHA after 6 hours using the hot plate test. Co-immunoprecipitation and immunoblotting studies were performed to determine the activation of the TRAF6/IKK/IkB-a/NF-kB pathway in the brains and spinal cords of animals. Latency to the thermal stimulus was reduced by 30% in LPS-injected endotoxemic mice compared with saline-injected mice. Treatment with DHA significantly improved latency compared with endotoxemic mice. In the brain and spinal cord of LPS-injected mice, treatment with DHA also prevented the increase in the expression and/or activity of (1) IKKa/IKKβ, IKKg, and K63 U in the NLRX1-immunoprecipitated tissues, (2) IKKa/IKKβ, K63 U, and K48 U in the IKKg-immunoprecipitated tissues, and (3) IkB-α, NF-kB p65, and interleukin-1β associated with decreased IkB-α expression. These findings suggest that inhibition of IKK/IkB-a/NF-kB signaling by dissociation of NLRX1 from TRAF6 in response to LPS treatment contributes to the protective effect of DHA against inflammatory hyperalgesia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BI-kappa B KinaseMaleMiceAnimalsLipopolysaccharidesTNF Receptor-Associated Factor 6Docosahexaenoic AcidsHyperalgesiaLigandsSignal TransductionMitochondrial Proteins

Substanzen

NF-kappa BI-kappa B KinaseLipopolysaccharidesTNF Receptor-Associated Factor 6Docosahexaenoic AcidsLigandsNLRX1 protein, mouseMitochondrial Proteins

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey. dilsahezgikucuk@hotmail.com.
  • Department of Pharmacy Services, Health Services Vocational School, Tarsus University, Tarsus, Mersin, Turkey. pnr.snl@hotmail.com.
  • Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey. meryemtemiz88@gmail.com.
  • Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey. seyhansahan06@gmail.com.
  • Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey. btunctan@gmail.com.

Zitieren

APA

Yilmaz, D. E., Senol, S. P., Temiz-Resitoglu, M., Sahan-Firat, S., & Tunctan, B. (2023). NLRX1 ligand, docosahexaenoic acid, ameliorates LPS-induced inflammatory hyperalgesia by decreasing TRAF6/IKK/IκB-α/NF-κB signaling pathway activity. Cellular and Molecular Biology. https://doi.org/10.14715/cmb/2023.69.9.3

Vancouver

Yilmaz DE, Senol SP, Temiz-Resitoglu M, Sahan-Firat S, Tunctan B. NLRX1 ligand, docosahexaenoic acid, ameliorates LPS-induced inflammatory hyperalgesia by decreasing TRAF6/IKK/IκB-α/NF-κB signaling pathway activity. Cellular and Molecular Biology. 2023. doi:10.14715/cmb/2023.69.9.3

BibTeX
@article{Yilmaz2023,
  author = {Yilmaz, Dilsah Ezgi and Senol, Sefika Pinar and Temiz-Resitoglu, Meryem and Sahan-Firat, Seyhan and Tunctan, Bahar},
  title = {NLRX1 ligand, docosahexaenoic acid, ameliorates LPS-induced inflammatory hyperalgesia by decreasing TRAF6/IKK/IκB-α/NF-κB signaling pathway activity},
  journal = {Cellular and Molecular Biology},
  year = {2023},
  doi = {10.14715/cmb/2023.69.9.3}
}
Kostenlos starten →